Tobacco Cessation among American Indian Cancer Survivors in Cherokee Nation

切罗基族美洲印第安人癌症幸存者戒烟

基本信息

批准号：
10478230
负责人：
Amanda E Janitz
金额：
$ 3.17万
依托单位：
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-09-15 至 2024-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10478230
关键词：
Accounting Adult Age American Indians Area Cancer Center Cancer Patient Cancer Survivor Caring Cessation of life Cherokee Indian Cherokee Nation, Oklahoma Chronic Clinic Consolidated Framework for Implementation Research Counseling Data Diagnosis Enrollment Ethnic group Evidence based intervention Future General Population Goals Health Expenditures Health system Healthcare High Prevalence Incidence Individual Intervention Intervention Studies Interview Malignant Neoplasms Mental Health Mentors Methods Morbidity - disease rate National Health Interview Survey Oklahoma Oncologist Oncology Participant Patients Persons Pharmaceutical Preparations Population Prevalence Primary Health Care Provider Race Relapse Reporting Research Research Personnel Reservations Resources Risk Role Second Primary Cancers Smoking Students Survivors System Time Tobacco Tobacco Use Cessation Tobacco use Tobacco-Related Carcinoma Tribes United States United States Indian Health Service Universities Work anticancer research cancer care cancer diagnosis care providers care systems career compare effectiveness education research evidence base experience former smoker future implementation health care service health disparity implementation research implementation strategy improved insight medical specialties member mortality productivity loss programs quitline reduce tobacco use smoking cessation success tobacco cessation intervention tobacco user tribal health undergraduate student vaping

项目摘要

Abstract Tobacco use is the leading cause of morbidity and mortality in the US, accounting for 30% of cancer deaths and resulting in more than $300 billion in annual health care expenditures and productivity loss. American Indian (AI) adults continue to have a higher prevalence of tobacco use (32%) compared to any other race/ethnic group (13%-25%) in the US and experience disproportionate rates of tobacco-related morbidity and mortality. In addition, AI individuals in Oklahoma have the highest age-adjusted cancer incidence (637 per 100,000) and mortality (255 per 100,000) rates compared to other racial groups. Continued use of tobacco after a cancer diagnosis increases the risk of secondary cancers and mortality compared to non-tobacco users. Cherokee Nation is the largest tribe in the United States with more than 378,000 enrolled members, and reducing tobacco use is one of the tribe's top priorities. Cherokee Nation works with Indian Health Service (IHS) to provide healthcare services for the AI population within their reservation area. Because of this system, any referral for specialty care not provided by Cherokee Nation must obtain approval through the IHS Purchased and Referred Care system, which may complicate oncology care. Furthermore, it is unclear whether AI cancer survivors routinely receive tobacco cessation treatment during their oncology care or while receiving primary care within the Cherokee Nation Health System. Our long-term goal is to reduce the prevalence of tobacco use among cancer survivors in Cherokee Nation. Our study aims to 1) evaluate tobacco cessation experiences among AI cancer survivors in Cherokee Nation; 2) identify current tobacco cessation practices in primary care and oncology settings, along with facilitators and barriers to delivering cessation treatment to Cherokee Nation cancer patients; and 3) develop tailored strategies to increase implementation and reach of tobacco cessation treatment for cancer survivors in Cherokee Nation. This study will provide insight into current practices and needs related to tobacco cessation for AI cancer survivors in Cherokee Nation. This project will provide preliminary data for an R01 proposal to compare the effectiveness of implementation strategies aimed at improving tobacco cessation treatment provided to cancer survivors. It will also provide opportunities for future implementation research focused on other evidence-based interventions for cancer survivors in Cherokee Nation.

抽象的烟草使用是美国发病率和死亡率的主要原因，占癌症死亡人数的 30% 并导致每年超过 3000 亿美元的医疗保健支出和生产力损失。美国人与其他任何国家相比，印度 (AI) 成年人的烟草使用率仍然较高 (32%) 美国的种族/族裔群体 (13%-25%) 与烟草相关的发病率不成比例死亡。此外，俄克拉荷马州的人工智能个体的年龄调整癌症发病率最高（每人 637 例）与其他种族群体相比，死亡率（每 100,000 人中有 255 人）和死亡率（每 100,000 人有 255 人）。继续使用烟草与不吸烟者相比，癌症诊断后继发性癌症和死亡率的风险增加。切罗基族是美国最大的部落，拥有超过 378,000 名注册成员，减少烟草使用是该部落的首要任务之一。切罗基民族与印度卫生服务机构合作 (IHS) 为其保留区内的人工智能人群提供医疗保健服务。因为有了这个系统，任何非 Cherokee Nation 提供的特殊护理转介必须获得 IHS 的批准购买和转介的护理系统可能会使肿瘤护理复杂化。此外，还不清楚 AI 癌症幸存者是否在肿瘤护理期间或期间定期接受戒烟治疗在切罗基国家卫生系统内接受初级护理。我们的长期目标是减少切罗基族癌症幸存者中烟草使用的流行率。我们的研究目的是 1) 评估烟草切罗基族人工智能癌症幸存者的戒烟经历； 2) 确定当前的戒烟情况初级保健和肿瘤学环境中的实践，以及戒烟的促进因素和障碍对切罗基族癌症患者的治疗； 3) 制定量身定制的战略以加强实施切罗基族癌症幸存者的戒烟治疗范围。这项研究将提供深入了解切罗基人工智能癌症幸存者与戒烟相关的当前实践和需求国家。该项目将为 R01 提案提供初步数据，以比较以下方案的有效性：旨在改善向癌症幸存者提供的戒烟治疗的实施战略。它将还为未来重点关注其他循证干预措施的实施研究提供机会为切罗基族的癌症幸存者提供帮助。